| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $38.1M | +27.1% |
| SG&A Expense | $12.2M | +5.0% |
| Operating Income | -$50.4M | -20.9% |
| Pre-tax Income | -$42.5M | -8.3% |
| Income Tax | $0 | — |
| Net Income | -$42.5M | -8.3% |
| EPS (Basic) | -$0.33 | +10.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.2M | -30.7% |
| Short-term Investments | $128.2M | -15.4% |
| Current Assets | $153.9M | -21.0% |
| Total Assets | $156.9M | -21.4% |
| Current Liabilities | $7.8M | -51.8% |
| Total Liabilities | $8.3M | -53.7% |
| Stockholders' Equity | $148.5M | -18.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.6M | -19.0% |
| Capital Expenditures | $30K | -85.8% |
| Investing Cash Flow | $27.0M | +117.8% |
| Financing Cash Flow | $2.9M | -96.1% |
| Free Cash Flow | -$40.6M | -18.4% |